Home > Insider Trading > Filing (0000899243-21-033561)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501134	Invitae Corp	NVTA	Services-Medical Laboratories (8071)	271701898

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640322	L Robert Nussbaum	C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-08-16	21,231	$25.42	246,050	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
Represents a weighted average sale price. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.
Includes an aggregate of 84,134 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
In addition to the transaction being reported, the total amount of securities is 402 shares greater than the reporting person's prior report, which reflects (a) the sale of an additional 66 shares on February 13, 2017, which number of shares subject to the sale was incorrectly reported in a Form 4 filed on February 15, 2017, (b) the sale of an additional 1,198 shares on May 15, 2018, which number of shares subject to the sale was incorrectly reported in a Form 4 filed on May 16, 2018 and (c) an unreported exercise of options for 1,666 shares of common stock, which occurred on January 3, 2017.